Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.
about
CIViC databaseDual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo.PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas.Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitroTargeted therapy in the treatment of uterine serous carcinoma.Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
P2860
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@ast
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@en
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@nl
type
label
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@ast
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@en
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@nl
altLabel
Afatinib demonstrates remarkab ...... al cancer in vitro and in vivo
@en
prefLabel
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@ast
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@en
Afatinib demonstrates remarkab ...... l cancer in vitro and in vivo.
@nl
P2093
P2860
P50
P356
P1476
Afatinib demonstrates remarkab ...... al cancer in vitro and in vivo
@en
P2093
A D Santin
C L Schwab
D P English
D-A Silasi
I Bortolomai
P E Schwartz
P2860
P2888
P304
P356
10.1038/BJC.2014.519
P407
P577
2014-09-30T00:00:00Z
P5875
P6179
1052838352